Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 4756 (MIR4756) is a small, non-coding RNA molecule in humans belonging to the microRNA (miRNA) family[7]. Like other microRNAs, it regulates gene expression by binding to target messenger RNAs (mRNAs), leading to their degradation or inhibition of translation[5][6][7]. MIR4756 is transcribed as a short RNA of approximately 20–24 nucleotides and is annotated as hsa-mir-4756 in human genome references[7]. Although the specific biological processes and disease associations for MIR4756 are not well characterized in the literature, the microRNA class is generally involved in numerous cellular processes including post-transcriptional gene regulation and may have roles in cell differentiation, proliferation, apoptosis, and homeostasis[6][9][13]. No drugs are currently known to specifically interact with MIR4756, nor is it established as a direct therapeutic target.
Gene silencing through binding to complementary mRNA sequences; mRNA degradation or translational repression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4756 (MIR4756).